Literature DB >> 32102980

Detection of subtle gait disturbance and future fall risk in early multiple sclerosis.

Rachel Brandstadter1, Oluwasheyi Ayeni1, Stephen C Krieger1, Noam Y Harel1, Miguel X Escalon1, Ilana Katz Sand1, Victoria M Leavitt1, Michelle T Fabian1, Korhan Buyukturkoglu1, Sylvia Klineova1, Claire S Riley1, Fred D Lublin1, Aaron E Miller1, James F Sumowski2.   

Abstract

OBJECTIVE: To test the hypothesis that higher-challenge gait and balance tasks are more sensitive than traditional metrics to subtle patient-reported gait dysfunction and future fall risk in early multiple sclerosis (MS).
METHODS: Persons with early MS (n = 185; ≤5 years diagnosed) reported gait function (MS Walking Scale) and underwent traditional disability metrics (Expanded Disability Status Scale [EDSS], Timed 25 Foot Walk). Patients and healthy controls (n = 50) completed clinically feasible challenge tasks of gait endurance (2-Minute Walk Test), standing balance (NIH Toolbox), and dynamic balance (balance boards; tandem walk on 2 ten-foot boards of different widths, 4.5 and 1.5 in). MRI assessed global and regional brain volumes, total T2 lesion volume (T2LV), infratentorial T2LVs and counts, and cervical cord lesion counts. Falls, near falls, and fall-related injuries were assessed after 1 year. We examined links between all tasks and patient-reported gait, MRI markers, and fall data.
RESULTS: Patients performed worse on higher challenge balance, but not gait, tasks compared with healthy controls. Worse patient-reported gait disturbance was associated with worse performance on all tasks, but only dynamic balance was sensitive to mild patient-reported gait difficulty. Balance tasks were more correlated with MRI metrics than were walking tasks or EDSS score. Thirty percent of patients reported either a fall or near fall after 1 year, with poor dynamic balance as the only task independently predicting falls.
CONCLUSIONS: Balance plays a leading role in gait dysfunction early in MS. Clinically feasible higher-challenge balance tasks were most sensitive to patient-reported gait, MRI disease markers, and risk of future falls, highlighting potential to advance functional outcomes in clinical practice and trials.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Year:  2020        PMID: 32102980      PMCID: PMC7274914          DOI: 10.1212/WNL.0000000000008938

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  43 in total

1.  Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.

Authors:  Stephen M Smith; Yongyue Zhang; Mark Jenkinson; Jacqueline Chen; P M Matthews; Antonio Federico; Nicola De Stefano
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

2.  Motor determinants of gait in 100 ambulatory patients with multiple sclerosis.

Authors:  P Thoumie; D Lamotte; S Cantalloube; M Faucher; G Amarenco
Journal:  Mult Scler       Date:  2005-08       Impact factor: 6.312

3.  Distinguishing among multiple sclerosis fallers, near-fallers and non-fallers.

Authors:  Nora E Fritz; Ani Eloyan; Moira Baynes; Scott D Newsome; Peter A Calabresi; Kathleen M Zackowski
Journal:  Mult Scler Relat Disord       Date:  2017-11-22       Impact factor: 4.339

4.  Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2011-01       Impact factor: 5.562

5.  Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia.

Authors:  Yeliz Salcı; Ayla Fil; Hilal Keklicek; Barış Çetin; Kadriye Armutlu; Anıl Dolgun; Aslı Tuncer; Rana Karabudak
Journal:  Mult Scler Relat Disord       Date:  2017-09-29       Impact factor: 4.339

6.  Risk factors for falling among people aged 45 to 90 years with multiple sclerosis.

Authors:  Marcia L Finlayson; Elizabeth W Peterson; Chi C Cho
Journal:  Arch Phys Med Rehabil       Date:  2006-09       Impact factor: 3.966

7.  Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment.

Authors:  Michelle H Cameron; Joanne M Wagner
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

8.  Fracture history and bone loss in patients with MS.

Authors:  F Cosman; J Nieves; L Komar; G Ferrer; J Herbert; C Formica; V Shen; R Lindsay
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

9.  Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable.

Authors:  C Heesen; J Böhm; C Reich; J Kasper; M Goebel; S M Gold
Journal:  Mult Scler       Date:  2008-05-27       Impact factor: 6.312

10.  Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).

Authors:  J C Hobart; A Riazi; D L Lamping; R Fitzpatrick; A J Thompson
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

View more
  6 in total

1.  Consensus Paper: Ataxic Gait.

Authors:  Pierre Cabaraux; Sunil K Agrawal; Huaying Cai; Rocco Salvatore Calabro; Carlo Casali; Loic Damm; Sarah Doss; Christophe Habas; Anja K E Horn; Winfried Ilg; Elan D Louis; Hiroshi Mitoma; Vito Monaco; Maria Petracca; Alberto Ranavolo; Ashwini K Rao; Serena Ruggieri; Tommaso Schirinzi; Mariano Serrao; Susanna Summa; Michael Strupp; Olivia Surgent; Matthis Synofzik; Shuai Tao; Hiroo Terasi; Diego Torres-Russotto; Brittany Travers; Jaimie A Roper; Mario Manto
Journal:  Cerebellum       Date:  2022-04-12       Impact factor: 3.847

2.  Machine learning to investigate superficial white matter integrity in early multiple sclerosis.

Authors:  Korhan Buyukturkoglu; Christopher Vergara; Valentina Fuentealba; Ceren Tozlu; Jacob B Dahan; Britta E Carroll; Amy Kuceyeski; Claire S Riley; James F Sumowski; Carlos Guevara Oliva; Ranganatha Sitaram; Pamela Guevara; Victoria M Leavitt
Journal:  J Neuroimaging       Date:  2021-09-17       Impact factor: 2.486

3.  Sleep disturbance and memory dysfunction in early multiple sclerosis.

Authors:  James F Sumowski; Sam Horng; Rachel Brandstadter; Stephen Krieger; Victoria M Leavitt; Ilana Katz Sand; Michelle Fabian; Sylvia Klineova; Robin Graney; Claire S Riley; Fred D Lublin; Aaron E Miller; Andrew W Varga
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

4.  Dietary factors and MRI metrics in early Multiple Sclerosis.

Authors:  I B Katz Sand; Kathryn C Fitzgerald; Yian Gu; Rachel Brandstadter; Claire S Riley; Korhan Buyukturkoglu; Victoria M Leavitt; Stephen Krieger; Aaron Miller; Fred Lublin; Sylvia Klineova; Michelle Fabian; James F Sumowski
Journal:  Mult Scler Relat Disord       Date:  2021-05-19       Impact factor: 4.808

5.  Walking With Horizontal Head Turns Is Impaired in Persons With Early-Stage Multiple Sclerosis Showing Normal Locomotion.

Authors:  Ilaria Carpinella; Elisa Gervasoni; Denise Anastasi; Rachele Di Giovanni; Andrea Tacchino; Giampaolo Brichetto; Paolo Confalonieri; Claudio Solaro; Marco Rovaris; Maurizio Ferrarin; Davide Cattaneo
Journal:  Front Neurol       Date:  2022-01-28       Impact factor: 4.003

6.  The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice.

Authors:  Katrin Trentzsch; Marie Luise Weidemann; Charlotte Torp; Hernan Inojosa; Maria Scholz; Rocco Haase; Dirk Schriefer; Katja Akgün; Tjalf Ziemssen
Journal:  Front Neurosci       Date:  2020-10-26       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.